Oxidative stress and NRF2 signaling in kidney injury

Cherry Ng1, Maxine Kim1, Yanti2

  • 1Department of Pharmacy and BK21FOUR Advanced Program for Smart Pharma Leaders, Graduate School of The Catholic University of Korea, Gyeonggi-do, 14662 Republic of Korea.

Toxicological Research
|February 27, 2025
PubMed

Insights

Targeting the NRF2 pathway shows promise for treating kidney diseases like acute kidney injury (AKI) and chronic kidney disease (CKD). Activating NRF2 (nuclear factor erythroid 2-related factor 2) can protect kidneys from damage and reduce fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathophysiology

Background:

  • Oxidative stress is a key factor in the development and progression of kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD).
  • The nuclear factor erythroid 2-related factor 2 (NRF2) is a critical regulator of cellular antioxidant responses and redox homeostasis.
  • Dysregulation of NRF2 contributes to kidney damage in various pathological conditions.

Purpose of the Study:

  • To review the complex interplay between oxidative stress and kidney pathophysiology.
  • To explore the therapeutic potential of NRF2 activation in mitigating kidney damage and fibrosis.
  • To discuss the clinical implications and challenges of targeting NRF2 for kidney disorders.

Main Methods:

  • Review of existing literature on oxidative stress, NRF2, and kidney disease.
  • Analysis of data from preclinical models of AKI and CKD.
  • Examination of findings from clinical trials involving NRF2 activators.

Main Results:

  • Reduced NRF2 activity worsens kidney damage in AKI and CKD models.
  • NRF2 activation demonstrates renoprotective effects against various insults, including toxins, ischemia-reperfusion, and diabetic nephropathy.
  • NRF2 exerts anti-inflammatory and anti-fibrotic effects, partly through interaction with TGF-β signaling.

Conclusions:

  • NRF2 activation holds significant therapeutic potential for managing kidney diseases.
  • Modulating NRF2 activity in humans presents complexities, as evidenced by clinical trial outcomes.
  • Further research is essential to optimize NRF2-targeted therapies for renal disorders.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.1K
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
9.2K